
Itamar Medical Ltd. ITMR
Itamar Medical Ltd. Gross Profit 2011-2026 | ITMR
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Itamar Medical Ltd.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 28.7 M | 24.3 M | 18.5 M | 15.7 M | 13.5 M | 12.4 M | 11.6 M | 9.08 M | 9.62 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 28.7 M | 9.08 M | 15.9 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
532 M | $ 12.37 | -4.85 % | $ 1.86 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
11.1 M | - | 1.37 % | $ 20.5 M | ||
|
Electromed
ELMD
|
50 M | $ 24.26 | -0.12 % | $ 205 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
1.65 B | $ 38.61 | 0.29 % | $ 5.75 K | ||
|
FONAR Corporation
FONR
|
42.4 M | $ 18.59 | 0.32 % | $ 122 M | ||
|
Cognyte Software Ltd.
CGNT
|
247 M | $ 8.29 | 1.22 % | $ 595 M | ||
|
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
89.3 M | $ 9.7 | 0.31 % | $ 1.31 B | ||
|
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
750 M | $ 41.54 | -3.37 % | $ 1.29 B | ||
|
EDAP TMS S.A.
EDAP
|
26.6 M | $ 4.19 | -1.41 % | $ 156 M | ||
|
Cutera
CUTR
|
-12.7 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 M | $ 29.14 | -0.27 % | $ 1.34 B | ||
|
Apyx Medical Corporation
APYX
|
33.8 M | $ 3.26 | -1.21 % | $ 113 M | ||
|
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
14.3 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
62 M | $ 1.59 | 10.07 % | $ 62.2 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | ||
|
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
147 M | $ 0.51 | -2.68 % | $ 52.4 M | ||
|
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | ||
|
Medtronic PLC
MDT
|
19.6 B | $ 92.77 | -2.97 % | $ 119 B | ||
|
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
25.1 M | $ 0.81 | 1.92 % | $ 44.1 M | ||
|
Align Technology
ALGN
|
2.8 B | $ 174.88 | -4.0 % | $ 13.1 B | ||
|
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
48.8 M | $ 3.69 | -8.56 % | $ 781 M | ||
|
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
18.7 B | $ 110.83 | -2.01 % | $ 193 B | ||
|
InMode Ltd.
INMD
|
291 M | $ 13.48 | -0.57 % | $ 871 M | ||
|
Orthofix Medical
OFIX
|
566 M | $ 12.56 | -2.41 % | $ 497 M | ||
|
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
13.9 B | $ 72.16 | -0.07 % | $ 107 B | ||
|
IRadimed Corporation
IRMD
|
56.3 M | $ 99.47 | -5.37 % | $ 1.26 B | ||
|
Insulet Corporation
PODD
|
1.94 B | $ 239.77 | -1.29 % | $ 16.9 B | ||
|
Profound Medical Corp.
PROF
|
4.38 M | - | - | $ 180 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.4 | -0.71 % | $ 22.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
173 M | $ 17.63 | -4.6 % | $ 414 M |